查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
止血带全球市场 2023-2030
市场调查报告书
商品编码
1217638

止血带全球市场 2023-2030

Global Tourniquet Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

止血带的全球市场规模预计到 2021 年将达到 3.9085 亿美元，到 2029 年将达到 6.7821 亿美元，在预测期内（2022-2029 年）以 7.9% 的复合年增长率增长。据说

使用止血带是骨科和整形外科中常见的做法。 最大限度阻断血流，创造无血手术野，抑制围手术期出血的加压装置。 它还用于静脉局部麻醉（啤酒阻滞）以抑制局部麻醉剂向中心扩散。

市场动态

在预测期内，骨科和整形外科手术数量的增加、交通事故伤害的增加等正在推动止血带市场的增长。

止血带在世界各地的肢体手术中得到了常规和安全的使用。 因此，骨科和整形手术的增加将推动全球止血带市场的增长。 例如，根据欧盟2020年统计数据，2020年德国每10万人约有294次膝关节置换，芬兰、奥地利、荷兰（2019年数据），丹麦每10万人约有250至269次膝关节置换，其中有成为欧盟成员国中最常见的 此外，除马耳他外，全膝关节置换术不如全髋关节置换术常见。 例如，到 2020 年，芬兰和德国每 10 万人口中将有超过 200 例全膝关节置换术。

此外，根据美国关节置换登记处2021，2021年将有超过1150家提供数据的机构进行超过240万例髋关节和膝关节手术，手术总数较2020年增加18.3 %。 同样，根据美国整形外科学院的数据，2020年将有大约1560万例整容手术，其中包括230万例整容手术和1320万例微创整容手术，以及大约680万例重建手术。据说已经完成了. 此外，越来越多的交通事故也促进了全球止血带市场的增长。 例如，据世界卫生组织统计，每年约有130万人死于道路突发事件。 大约有 20 至 5000 万人遭受非致命伤害。 此外，疾病预防控制中心提供了 2020 年需要手术的非致命伤害的统计数据，大约有 2,885,545 例门诊病例。 从以上数据来看，全球越来越多的骨科手术、整形手术和道路交通事故正在推动全球止血带市场的增长。

止血带损伤的发生抑制了全球止血带市场的增长。

然而，止血带在手术中的隐患在于，它威胁到临床皮肤、肌肉、血管、结缔组织和神经的损伤，因为麻木、麻痹和瘫痪伴有肌肉萎缩。 其中，缺氧和酸中毒主要引起组织缺血和肌肉损伤。 此外，止血带释放后灌注会导致生理性高血压、体温过低和氧应激，从而导致有毒代谢物再灌注到体循环中。 与使用此类止血带相关的并发症在预测期内限制了全球市场的增长。

COVID-19 的影响

在 COVID-19 流行期间，对社交和社交聚会的限制减少了道路交通伤亡、运动损伤和其他需要手术干预的医疗状况，导致全球市场增长放缓。 例如，根据国际美容整形外科学会的数据，整形手术在大流行期间有所下降。 大约 10.9%，大约 78% 的外科医生经历了临时诊所关闭。 此外，根据国家公共卫生研究所的数据，在大流行的第一年，骨科手术减少了约 23%。 其中，膝关节置换术的影响最大。 髋关节置换手术减少了约 64%，膝关节韧带重建手术减少了约 41%、44%，对止血带的需求也降低了。 这些统计数据表明，止血带市场已受到 COVID-19 大流行的负面影响。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 骨科和整形外科手术人数增加
      • 交通事故增加
    • 约束因素
      • 止血带造成的伤害
    • 商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章（按组件）

  • 止血带装置
  • 止血带袖口
    • 气动止血带袖口
    • 非气动止血带袖口

第 8 章应用

  • 上肢手术
  • 下肢手术
  • 其他

第 9 章最终用户

  • 医院和诊所
  • 门诊手术中心
  • 骨科诊所

第10章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第11章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准

第12章公司简介

  • 捷迈邦美
    • 公司概况
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • Stryker
  • ATMOS MedizinTechnik GmbH & Co. KG
  • VBM
  • DDM
  • Anetic Aid
  • HPM
  • Huifeng Medical
  • DS MAREF
  • Bohus Medical

第13章 DataM

简介目录
Product Code: DMMD2821

Market Overview

The global tourniquet market size was valued at US$ 390.85 million in 2021 and is estimated to reach US$ 678.21 million by 2029, growing at a CAGR of 7.9% during the forecast period (2022-2029).

Tourniquet use is a familiar approach in orthopedic and plastic surgeries. They are compressive instruments that block blood flow to the extremes to produce a bloodless surgical field and reduce perioperative blood loss. They are also employed for intravenous regional anesthesia (Bier's block) to control the central spread of local anesthetics.

Market Dynamics

The growing number of orthopedic surgeries, plastic surgeries and the increasing incidents of road accident trauma drive the tourniquet Market growth during the forecast period.

Tourniquets are regularly and safely utilized in extremities surgeries throughout the globe. Thus, the increasing number of orthopedic and plastic surgeries boosts global tourniquet market growth. For instance, according to the European Union 2020 statistics, hip replacements were performed about 294 times per 100 000 residents in Germany in 2020 and between 250 and 269 times per 100 000 inhabitants in Finland, Austria, and the Netherlands (2019 data) and Denmark; these were the most elevated commonnesses among the EU Member States for which data are known, knee replacements varied more between the EU Member States than did hip replacements. Furthermore, except for Malta, total knee replacements were less common than hip replacements. For instance, in 2020, more than 200 knee replacements per 100 000 inhabitants were performed in Finland and Germany.

In addition, according to the American Joint Replacement Registry 2021, over 2.4 million hip and knee surgeries from over 1150 institutions that presented data took place in 2021, representing an 18.3% upsurge in total procedural volume compared with that in 2020. Likewise, according to the American Society of Plastic Surgeons, around 15.6 million cosmetic procedures comprised 2.3 million cosmetic surgical procedures and 13.2 million cosmetic minimally-invasive procedures, and about 6.8 million reconstructive procedures were performed in 2020. Besides, the increasing number of road accidents contributes to the growth of the global tourniquet Market. For example, according to statistics from the world health organization, roughly 1.3 million people die yearly from road casualty emergencies. Almost 20-50 million individuals suffer from non-fatal injuries. Moreover, the CDC has supplied statistics of non-fatal injuries needing surgery in 2020, with approximately 2,885,545 ambulatory cases. From the data mentioned above, the rising number of orthopedic surgeries, plastic surgeries and incidents of road accidents worldwide is pushing the global tourniquet market growth.

The incidences of tourniquet injuries will restrain the global tourniquet market growth.

However, the implication of a tourniquet in surgery is the threat of clinical skin, muscle, blood vessels, connective tissue, and nerve damage because of numbness, paresis, or paralysis with muscle atrophy. Among these, hypoxia and acidosis primarily induce tissue ischemia and muscle damage. Furthermore, after releasing the tourniquet, perfusion leads to a physiological elevation in blood pressure, lowered body temperature, and oxygen stress, which is connected to the reentry toxic metabolites back into the systemic circulation. Such complications associated with tourniquet use are restraining the global market growth in the forecast period.

COVID-19 Impact.

During the COVID-19 pandemic, the constraint on socializing and social assemblages lessened the numeral of road traffic casualties, sports harms, and other medical ailments demanding surgical intervention, forcing a decline in the market growth globally. For example, according to the International Society of Aesthetic Plastic Surgery, plastic surgery procedures dropped during the pandemic. Approximately 10.9% and around 78% of surgeons experienced temporary practice closure. Furthermore, according to the national health institute, orthopedic surgery was down by about 23% during the first pandemic year. Among which orthopedic surgeries, knee arthroplasty had the utmost influence. It was down by almost 64%, pursued by hip arthroplasty and knee ligament reconstruction by about 41% and 44%, respectively, lessening the need for a tourniquet market. These statistics show that the tourniquet market was negatively impacted by the COVID-19 pandemic globally.

Segment Analysis

Tourniquet systems are expected to dominate the market throughout the forecast period (2022-2029).

The increasing access to specialty care products, pathological products, clinical examination, and diagnosis at a single premise is best possible in hospitals, indicating an exponential segment growth. Hospitals are the major end-user facilities for tourniquets. Moreover, the increasing numeral of sports-related injuries and road casualties raises the number of orthopedic cases, thereby driving the need for hospital-related cases. According to the National Safety Council (NSC), over 55.4 million injuries were experienced in the United States, a 15.7% increase from 2019 to 2020. The Bureau of Labor Statistics (BLS) reports that private industry employers registered over 2.7 million nonfatal workplace injuries and illnesses in 2020. The preventable injuries in the home in 2020 were about 31,800,000 means that one person in 10 in the U.S. encountered a medically consulted injury. Likewise, bicycling accounted for about 426,000 injuries in 2020. According to the National Center for Health Statistics, part of the Centers for Disease Control and Prevention, hospital emergency rooms across the country receive over 145.6 million patients annually.

Old people are more susceptible to orthopedic disorders. According to the World Population Aging globally, there were 727 million persons aged 65 years or over in 2020. Since women live longer than men, they comprise the majority of older persons, especially at advanced ages. This rise in life expectancies and age-related comorbidities results in the growth of geriatric orthopedic surgical procedures. Additionally, the central government offers partial or complete coverage for in-home services in most developed and developing nations. In the U.S., Medicare reimbursements are highly favorable in providing value-based healthcare for improved patient outcomes at a low cost. Thus, from the mentioned data, it is estimated that the hospital end user will dominate the global tourniquet market throughout the forecast period.

Geographical Analysis

The North American region holds the largest global Tourniquet market share.

North American tourniquets market will grow at high CAGR throughout the forecast period (2022-2029). According to the International Society of Aesthetic Plastic Surgery, the U.S. had an immense number of surgeons, with over 7,000 plastic surgeons in 2020, conducted across 3,182,815 non-surgical procedures and approximately 1,485,116 Surgical practices. Again, according to the same survey, the total number of operations executed in Mexico was over 860,718 in 2020. Likewise, from the data obtained by the U.S. Department of transportation`s fatality analysis reporting system, approximately 35,766 fatal vehicle crashes occurred in the U.S. in 2020, inducing roughly 38,824 deaths.

Additionally, there are presently nearly 18,380 orthopedic surgeons in America practicing, indicating that North America maintains a major market share. Another reason North America owns a significant market share is the risen prevalence of obesity. For example, according to the National data from the 2017-2020 National Health and Nutrition Examination Survey, more than 41.9% of adults are obese. Therefore, from about mentioned data, it is predicted that North America will dominate the global Tourniquet Market during the forecast period (2022-2029).

Competitive Landscape

The tourniquet market is moderately competitive due to the presence of key local and global players. Some key players are Zimmer Biomet, Stryker, ATMOS MedizinTechnik GmbH & Co. KG, VBM, DDM, Anetic Aid, HPM, Huifeng Medical, DS MAREF, and Bohua Medical. These key players hold the major share of the market through innovations, product launches, collaborations, acquisitions, and alliances. For instance, in May 2021, ATMOS MedizinTechnik GmbH & Co. KG acquired the tourniquets device portfolio of Ulrich medical.

Zimmer Biomet

Overview:

Zimmer Biomet was in 1927 and has operations in more than 25 countries around the world and more than 100 countries to sell their product with a vast portfolio. Also, it is a leading company focusing on alleviating pain and improving the quality of life for people around the world.

Product Portfolio:

Zimmer Biomet's tourniquet product portfolio has A.T.S. 5000 Tourniquet Systems: The A.T.S. 5000 combines Personalized Pressure Technology with the new customizable user choosing to deliver a personalized experience for patients and healthcare professionals without disrupting workflow.

The global tourniquet market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Number of Orthopedic and Plastic Surgeries
      • 4.1.1.2. Increasing Incidents of Road Accidents
    • 4.1.2. Restraints
      • 4.1.2.1. Tourniquet Injuries
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Component

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 7.1.2. Market Attractiveness Index, By Component
  • 7.2. Tourniquet Instrument
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Tourniquet cuffs
    • 7.3.1. Pneumatic Tourniquet Cuffs*
    • 7.3.2. Non-Pneumatic Tourniquet Cuffs

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Upper-Limb Surgery
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Lower-Limb Surgery
  • 8.4. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals & Clinics
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Ambulatory Surgery Centers
  • 9.4. Orthopedic Clinics

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Company Profiles

  • 12.1. Zimmer Biomet
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Stryker
  • 12.3. ATMOS MedizinTechnik GmbH & Co. KG
  • 12.4. VBM
  • 12.5. DDM
  • 12.6. Anetic Aid
  • 12.7. HPM
  • 12.8. Huifeng Medical
  • 12.9. DS MAREF
  • 12.10. Bohus Medical

LIST NOT EXHAUSTIVE

13. DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us